Bausch & Lomb CORP Form 4 insider transactions

Director Eduardo Alfonso acquired 1,375 restricted share units of Bausch + Lomb Corporation at a price of $15.90 per share.

Andrew J. Stewart, President of GPIC at Bausch + Lomb, reported the withholding of 4,216 common shares to satisfy tax obligations.

EVP & Chief Legal Officer A. Robert D. Bailey disposed of 15,806 common shares to satisfy tax obligations related to RSU vesting.

Bausch + Lomb Corporation Director Thomas W. Ross Sr. acquired 4,500 common shares and received 4,500 matching restricted share units.

Bausch + Lomb Director Eduardo Alfonso acquired 4,300 common shares and received 4,300 matching restricted share units, increasing his beneficial ownership.

Frederick Munsch, SVP, Controller and CAO of Bausch + Lomb Corporation, reported the disposition of common shares to cover tax withholding obligations related to vested restricted share units.

Andrew J. Stewart, President of GPIC at Bausch + Lomb Corporation, disposed of common shares to cover tax withholding obligations related to restricted share unit vesting.

Bausch + Lomb's President of Surgical, Luc Bonnefoy, reported the disposition of common shares to cover tax withholdings related to RSU and PSU vesting.

Bausch + Lomb's EVP of R&D and CMO, Yehia Hashad, disposed of common shares to cover tax liabilities from vested restricted stock units.

Bausch + Lomb's EVP & Chief Legal Officer, A. Robert D. Bailey, reported the withholding of common shares to satisfy tax obligations upon the vesting of restricted share units.

Bausch + Lomb's EVP and CFO, Sam Eldessouky, reported the sale of 74,039 common shares to cover tax withholdings related to restricted share unit vesting.

Bausch + Lomb CEO Brent L. Saunders reported the disposition of shares to cover tax obligations related to the vesting of restricted stock units.

Frederick Munsch, SVP, Controller and CAO of Bausch + Lomb Corporation, was granted 18,253 restricted share units under the company's 2022 Omnibus Incentive Plan.

Luc Bonnefoy, President of Surgical at Bausch + Lomb, was granted 30,373 restricted share units under the company's incentive plan.

Andrew J. Stewart, President, GPIC of Bausch + Lomb Corporation, was granted 32,710 restricted share units as part of the company's 2022 Omnibus Incentive Plan.

Bausch + Lomb's EVP of R&D and CMO, Yehia Hashad, was granted 35,046 restricted share units, increasing his beneficial ownership.

Bausch + Lomb Corporation's EVP & Chief Legal Officer, Robert D. Bailey, was granted 52,570 restricted share units under the company's incentive plan.

Bausch + Lomb Corporation's EVP and CFO, Sam Eldessouky, was granted 81,775 restricted share units as part of the company's incentive plan.

Bausch + Lomb Corporation's CEO and Chairman, Brent L. Saunders, was granted 327,102 restricted share units under the company's 2022 Omnibus Incentive Plan.

Bausch + Lomb CEO Brent L. Saunders disposed of 65,444 common shares to cover tax obligations related to restricted share unit vesting.

Bausch + Lomb Director Steven H. Collis purchased 15,000 common shares and received 4,491 matching restricted share units.

Bausch + Lomb Director Russel C. Robertson acquired 4,400 common shares and received matching restricted share units, increasing his direct beneficial ownership.

Bausch & Lomb Director Karen Ling acquired 4,000 common shares and received 4,000 matching restricted share units, signaling increased insider confidence.

Bausch + Lomb Director Steven H. Collis was granted 5,255 restricted share units as part of the company's 2022 Omnibus Incentive Plan.

Bausch + Lomb Director Eduardo Alfonso received an annual grant of 5,255 restricted share units, vesting prior to the next annual shareholder meeting.

Bausch + Lomb Director Russel C. Robertson acquired 1,451 restricted share units, increasing his beneficial ownership to 68,007 shares.

Director and 10% owner John Paulson acquired 1,239 restricted share units of Bausch + Lomb Corporation common stock.

Bausch & Lomb (BLCO) director Russel C. Robertson reported an award of 1,642 RSUs at $15.6 on November 14, 2025, bringing direct ownership to 66,556 shares.

Bausch + Lomb Director and 10% owner John Paulson reported a planned acquisition of 1,402 common shares at $15.60, effective November 14, 2025, under a 10b5-1 plan.

Bausch + Lomb's SVP, Controller and CAO, Frederick Munsch, was awarded 7,529 common shares from performance stock units that met target conditions.